Form D · Biotechnology
Synthego Corp
Redwood City, CA · CIK 0001553025
Offering snapshot reported Oct 23, 2018 · SEC filing
- Reported sold
- $106M Offering amount: $116M
- Investors reported
- 29 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 9, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 23, 2018 | Initial | $106,273,601 | No comparison | 29 | SEC filing |
| Jan 4, 2017 | Initial | $40,696,687 | No comparison | 22 | SEC filing |
| Jul 5, 2013 | Initial | $8,294,226 | No comparison | 18 | SEC filing |
| Aug 14, 2012 | Initial | $250,000 | No comparison | 1 | SEC filing |
| Jun 26, 2012 | Initial | $205,000 | No comparison | 6 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-324114
Source: Form D, filed Oct 23, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Forrest Baringer Jones | Executive |
| Michael Jakub Dabrowski | Director, Executive |
| Paul John Dabrowski | Director, Executive |
| Scott Nolan | Director |
| Drew Oetting | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
3696 A Haven Avenue
Redwood City, CA, 94063
Redwood City, CA, 94063